Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2022-01-14 00:00:00 ET · period of report 2022-01-12 · accession 0001214659-22-000706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-14 | 2022-01-12 | ALLO | Kazam Joshua A | Dir | P - Purchase | $12.60 | +15.0K | 258.9K | +6% | +$189.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-12 | P | A | 15,000 | $12.60 | 258,885 | D | — | — |